Navigation Links
Dynatronics Announces Fiscal Second Quarter Results
Date:2/14/2011

t the vast number of clinics to our brand of products, we are already receiving requests for product quotes from GPO customers."

"As we begin to solicit sales orders under these GPO arrangements, we are gearing up our production capacity for a new level of operations," added Cullimore. "With over 12,000 products now available through our catalog and e-commerce website, we are in a good position to supply this high-volume segment of the physical medicine market."

Dynatronics has scheduled a conference call for investors on Monday, February 14, 2011, at 1:30 p.m. ET. Those wishing to participate should call (800) 926-7431 and use access code: 5687000.

Following is a summary of the financial results as of December 31, 2010, and June 30, 2010, and for the three and six month periods then ended:   Summary Selected Financial DataStatement of Income Highlights (Unaudited)Three Months EndedSix Months EndedDecember 31,December 31,2010200920102009Net sales

$8,199,347

$8,501,437

$16,118,635

$16,783,900Cost of sales

5,029,906

5,174,060

9,997,361

10,277,181Gross profit

3,169,441

3,327,377

6,121,274

6,506,719SG&A expenses

2,634,278

2,699,357

5,134,795

5,411,726R&D expenses

356,519

206,882

706,315

422,850Other expenses, net

65,604

110,936

137,387

220,167Net income before income taxes

113,040

310,202

142,777

451,976Income tax provision

(45,201)

(121,903)

(57,926)

(195,053)Net income

$67,839

$188,299

$84,851

$256,923Diluted income per common share

'/>"/>

SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dynatronics to Release Fiscal Second Quarter Results Monday, February 14, 2011; Conference Call Set for 1:30 p.m. ET
2. Dynatronics Named Contract Supplier to Amerinets 50,000 Members
3. Dynatronics Named Contract Supplier to Premier, Inc.
4. NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance
5. Dynatronics Announces Fiscal First Quarter Results
6. Dynatronics to Release Fiscal First Quarter Results Thursday, November 11, 2010; Conference Call Set for 2:15 p.m. ET
7. Dynatronics Announces Positive Year-end Results
8. Dynatronics to Release Fourth Quarter and Year-End Results Wednesday, September 22, 2010; Conference Call Set for 1:00 p.m. ET
9. Dynatronics Launches E-Commerce Website
10. Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter
11. Dynatronics to Release Third Quarter Results Monday, May 17, 2010; Conference Call Set for 1:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Sept. 3 Forest Laboratories, Inc.,(NYSE: ... announced results from,two global Phase III studies ... for the treatment of patients with chronic,obstructive ... I&II,(AClidinium CLinical Trial Assessing Efficacy and Safety ...
... Efficacy ... Endpoints, Company to Host Conference Call and Webcast Wednesday, September ... 8:30 am ET ... NBIX ) today announced positive safety and efficacy results,from its third Phase II clinical ...
Cached Medicine Technology:Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 2Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 3Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 4Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 6
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... IL, April 17, 2014-- Colic affects about one in ... for numerous pediatric visits during the first several months ... colic symptoms was showing promise; however, the April 1, ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and ... L reuteri for infant colic did ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... Dec. 4 In the midst of a ... in the United States,healthcare providers from across the ... headquarters in Redmond, Wash., for the first U.S.,Public ... to apply information technology (IT) innovations to solve ...
... Dec. 4 /PRNewswire-Asia-FirstCall/ -- Dozens of pre-screened,Greater China ... high note meeting top buyers,at Global Sources, (Nasdaq: ... http://www.PrivateSourcingEvents.com ) for sanitaryware & plumbing; ... toys; sporting,goods; and health & personal care products. ...
... having children feel responsible for the stored, frozen embryos ... are against implanting the embryos in anyone else, according ... Medical Center. , "This really turns our ... MD, an obstetrician/gynecologist and bioethicist at Duke, and lead ...
... gantry approach to coronary CT angiography reduced radiation exposure ... Thomas Jefferson University researchers. , Ethan Halpern, M.D., associate ... Jefferson University in Philadelphia, presented the research at the ... Society of North America. , "Radiation dose to the ...
... 3 ThermoGenesis,Corp. (Nasdaq: KOOL ), a ... store adult stem cells, said today that the call ... to discuss its announcement,regarding a management transition at the ... ThermoGenesis. , The ...
... for Fair and Affordable,Insurance Reform (CFAIR) is pleased to ... the need for individual insurance,market reform. , ... legislators, Ken Matzick, President and Chief,Executive Officer of Beaumont ... regulatory structure for individual health,insurance is in need of ...
Cached Medicine News:Health News:Microsoft, Penn State Hershey Medical Center Showcase Road Map to Patient Flow Efficiencies at First Healthcare Provider Symposium 2Health News:Microsoft, Penn State Hershey Medical Center Showcase Road Map to Patient Flow Efficiencies at First Healthcare Provider Symposium 3Health News:Microsoft, Penn State Hershey Medical Center Showcase Road Map to Patient Flow Efficiencies at First Healthcare Provider Symposium 4Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 2Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 3Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 4Health News:Largest study of fertility patients shows concerns about embryo disposition 2Health News:Largest study of fertility patients shows concerns about embryo disposition 3Health News:ThermoGenesis Corp. Provides Updated Information for Conference Call/Webcast to Discuss Management Transition 2Health News:Over 40 Hospitals Lend Support for Individual Insurance Market Reform 2
Surgitie&trade Single Use Ligating Loops with Delivery System...
Surgitie&trade Single Use Ligating Loops without Delivery System with POLYSORB™....
ENDO STITCH&trade Triple-Stitch Single Use Loading Units for use with ENDO Stitch* 10 mm Suturing Device....
ENDO STITCH™ Single Use Loading Units....
Medicine Products: